Amneal Pharmaceuticals Stock Guidance | NASDAQ:AMRX

Comments

Amneal Pharmaceuticals Inc Stock Guidance

AMRXNASDAQ

Trade with Public

$13.25

0.010.08%

At close: Mar 9, 5:00 PM EST

$13.32

0.070.53%

After Hours: 4:55 PM EST

Overview News Earnings OptionsGuidanceAnalyst Ratings Insider Trades Short Interest Stock Report

Amneal Pharmaceuticals (AMRX) last issued guidance on February 27, 2026 for fiscal year 2026. The company guided earnings per share in the range of $0.93 - $1.03, compared to a consensus EPS estimate of $0.92. Amneal Pharmaceuticals also guided revenue in the range of $3.05B - $3.15B for the period.

Compared to prior guidance, Amneal Pharmaceuticals raised its revenue forecast from a prior range of $3.00B - $3.10B.

Amneal Pharmaceuticals has issued 24 guidance updates between May 4, 2022 and February 27, 2026. During this period, the company raised its outlook 9 times and lowered it 4 times, providing investors with insight into management's evolving expectations.

Latest Guidance Date

Feb 27, 2026

Guidance Period

Full Year 2026

EPS Guidance Range

$0.93 - $1.03

Revenue Guidance Range

$3.05B - $3.15B

Amneal Pharmaceuticals Guidance History

Review all historical guidance issued by Amneal Pharmaceuticals, including EPS and revenue forecasts across quarterly and annual periods.

FAQ

What is the most recent guidance for Amneal Pharmaceuticals (AMRX)?

The most recent guidance for Amneal Pharmaceuticals (AMRX) was reported on February 27, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $0.93 to $1.03, compared to the estimated EPS of $0.92. Additionally, Amneal Pharmaceuticals forecasted revenue between $3.05B and $3.15B for the period.

What EPS range did Amneal Pharmaceuticals (AMRX) guide for?

Amneal Pharmaceuticals (AMRX) guided EPS in the range of $0.93 to $1.03 for the fiscal year 2026. The consensus analyst EPS estimate is $0.92.

What revenue range did Amneal Pharmaceuticals (AMRX) guide for?

Amneal Pharmaceuticals (AMRX) guided revenue in the range of $3.05B to $3.15B for the fiscal year 2026.

Did Amneal Pharmaceuticals (AMRX) raise or lower guidance?

Amneal Pharmaceuticals (AMRX) raised its revenue guidance from a prior range of $3.00B - $3.10B to $3.05B - $3.15B for the fiscal year 2026.

When did Amneal Pharmaceuticals (AMRX) last issue guidance?

Amneal Pharmaceuticals (AMRX) last issued guidance on February 27, 2026 for the fiscal year 2026.

People Also Watch

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

NASDAQ:AXSM

$164.49

Compared to prior guidance, Amneal Pharmaceuticals raised its revenue forecast from a prior range of $3.00B - $3.10B.

Latest Guidance Date

Feb 27, 2026

Guidance Period

Full Year 2026

EPS Guidance Range

$0.93 - $1.03

Revenue Guidance Range

$3.05B - $3.15B

Amneal Pharmaceuticals Guidance History

Review all historical guidance issued by Amneal Pharmaceuticals, including EPS and revenue forecasts across quarterly and annual periods.

											Get Alert
02/27/2026	AMRX	Amneal Pharmaceuticals	FY	2026	$0.93	$1.03	$0.92	$3.05B	$3.15B	$3.21B	Get Alert
01/13/2026	AMRX	Amneal Pharmaceuticals	FY	2025	$0.75	$0.80	$0.80	$3.00B	$3.10B	$3.01B	Get Alert
10/30/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.75	$0.80	$0.73	$3.00B	$3.10B	$3.01B	Get Alert
08/05/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.70	$0.75	$0.68	$3.00B	$3.10B	$3.02B	Get Alert
07/21/2025	AMRX	Amneal Pharmaceuticals	Q2	2025	—	—	$0.17	$720.00M	$730.00M	$749.64M	Get Alert
05/02/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.65	$0.70	$0.68	$3.00B	$3.10B	$3.03B	Get Alert
02/28/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.65	$0.70	$0.71	$3.00B	$3.10B	$2.92B	Get Alert
01/15/2025	AMRX	Amneal Pharmaceuticals	FY	2024	$0.57	$0.63	$0.61	$2.70B	$2.80B	$2.77B	Get Alert
11/08/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.57	$0.63	$0.60	$2.70B	$2.80B	$2.76B	Get Alert
08/09/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.57	$0.63	$0.61	$2.70B	$2.80B	$2.65B	Get Alert
05/03/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.53	$0.63	$0.58	$2.55B	$2.65B	$2.61B	Get Alert
03/01/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.53	$0.63	$0.60	$2.55B	$2.65B	$2.58B	Get Alert
11/07/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.51	$0.58	$0.55	$2.37B	$2.42B	$2.37B	Get Alert
10/23/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.51	$0.58	$0.55	$2.37B	$2.42B	$2.37B	Get Alert
10/23/2023	AMRX	Amneal Pharmaceuticals	Q3	2023	—	—	—	$610.00M	$620.00M	$585.69M	Get Alert
08/04/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.45	$0.55	$0.47	$2.30B	$2.40B	$2.32B	Get Alert
05/05/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.40	$0.50	$0.50	$2.25B	$2.35B	$2.32B	Get Alert
04/17/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.40	$0.50	$0.50	$2.25B	$2.35B	$2.31B	Get Alert
04/17/2023	AMRX	Amneal Pharmaceuticals	Q1	2023	—	—	—	$550.00M	$560.00M	$529.47M	Get Alert
03/02/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.40	$0.50	$0.77	$2.25B	$2.35B	$2.31B	Get Alert
01/10/2023	AMRX	Amneal Pharmaceuticals	FY	2022	$0.65	$0.70	$0.66	$2.15B	$2.25B	$2.18B	Get Alert
11/04/2022	AMRX	Amneal Pharmaceuticals	FY	2022	$0.65	$0.70	$0.68	$2.15B	$2.25B	$2.20B	Get Alert
08/05/2022	AMRX	Amneal Pharmaceuticals	FY	2022	$0.65	$0.70	$0.81	$2.15B	$2.25B	$2.17B	Get Alert
05/04/2022	AMRX	Amneal Pharmaceuticals	FY	2022	$0.80	$0.85	$0.84	$2.15B	$2.25B	$2.19B	Get Alert

FAQ

What is the most recent guidance for Amneal Pharmaceuticals (AMRX)?

What EPS range did Amneal Pharmaceuticals (AMRX) guide for?

Amneal Pharmaceuticals (AMRX) guided EPS in the range of $0.93 to $1.03 for the fiscal year 2026. The consensus analyst EPS estimate is $0.92.

What revenue range did Amneal Pharmaceuticals (AMRX) guide for?

Amneal Pharmaceuticals (AMRX) guided revenue in the range of $3.05B to $3.15B for the fiscal year 2026.

Did Amneal Pharmaceuticals (AMRX) raise or lower guidance?

Amneal Pharmaceuticals (AMRX) raised its revenue guidance from a prior range of $3.00B - $3.10B to $3.05B - $3.15B for the fiscal year 2026.

When did Amneal Pharmaceuticals (AMRX) last issue guidance?

Amneal Pharmaceuticals (AMRX) last issued guidance on February 27, 2026 for the fiscal year 2026.

People Also Watch

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

NASDAQ:AXSM

$164.49

											Get Alert
02/27/2026	AMRX	Amneal Pharmaceuticals	FY	2026	$0.93	$1.03	$0.92	$3.05B	$3.15B	$3.21B	Get Alert
01/13/2026	AMRX	Amneal Pharmaceuticals	FY	2025	$0.75	$0.80	$0.80	$3.00B	$3.10B	$3.01B	Get Alert
10/30/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.75	$0.80	$0.73	$3.00B	$3.10B	$3.01B	Get Alert
08/05/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.70	$0.75	$0.68	$3.00B	$3.10B	$3.02B	Get Alert
07/21/2025	AMRX	Amneal Pharmaceuticals	Q2	2025	—	—	$0.17	$720.00M	$730.00M	$749.64M	Get Alert
05/02/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.65	$0.70	$0.68	$3.00B	$3.10B	$3.03B	Get Alert
02/28/2025	AMRX	Amneal Pharmaceuticals	FY	2025	$0.65	$0.70	$0.71	$3.00B	$3.10B	$2.92B	Get Alert
01/15/2025	AMRX	Amneal Pharmaceuticals	FY	2024	$0.57	$0.63	$0.61	$2.70B	$2.80B	$2.77B	Get Alert
11/08/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.57	$0.63	$0.60	$2.70B	$2.80B	$2.76B	Get Alert
08/09/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.57	$0.63	$0.61	$2.70B	$2.80B	$2.65B	Get Alert
05/03/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.53	$0.63	$0.58	$2.55B	$2.65B	$2.61B	Get Alert
03/01/2024	AMRX	Amneal Pharmaceuticals	FY	2024	$0.53	$0.63	$0.60	$2.55B	$2.65B	$2.58B	Get Alert
11/07/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.51	$0.58	$0.55	$2.37B	$2.42B	$2.37B	Get Alert
10/23/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.51	$0.58	$0.55	$2.37B	$2.42B	$2.37B	Get Alert
10/23/2023	AMRX	Amneal Pharmaceuticals	Q3	2023	—	—	—	$610.00M	$620.00M	$585.69M	Get Alert
08/04/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.45	$0.55	$0.47	$2.30B	$2.40B	$2.32B	Get Alert
05/05/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.40	$0.50	$0.50	$2.25B	$2.35B	$2.32B	Get Alert
04/17/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.40	$0.50	$0.50	$2.25B	$2.35B	$2.31B	Get Alert
04/17/2023	AMRX	Amneal Pharmaceuticals	Q1	2023	—	—	—	$550.00M	$560.00M	$529.47M	Get Alert
03/02/2023	AMRX	Amneal Pharmaceuticals	FY	2023	$0.40	$0.50	$0.77	$2.25B	$2.35B	$2.31B	Get Alert
01/10/2023	AMRX	Amneal Pharmaceuticals	FY	2022	$0.65	$0.70	$0.66	$2.15B	$2.25B	$2.18B	Get Alert
11/04/2022	AMRX	Amneal Pharmaceuticals	FY	2022	$0.65	$0.70	$0.68	$2.15B	$2.25B	$2.20B	Get Alert
08/05/2022	AMRX	Amneal Pharmaceuticals	FY	2022	$0.65	$0.70	$0.81	$2.15B	$2.25B	$2.17B	Get Alert
05/04/2022	AMRX	Amneal Pharmaceuticals	FY	2022	$0.80	$0.85	$0.84	$2.15B	$2.25B	$2.19B	Get Alert

Benzinga

Benzinga

Amneal Pharmaceuticals Inc Stock Guidance

Amneal Pharmaceuticals Guidance History

FAQ

What is the most recent guidance for Amneal Pharmaceuticals (AMRX)?

What EPS range did Amneal Pharmaceuticals (AMRX) guide for?

What revenue range did Amneal Pharmaceuticals (AMRX) guide for?

Did Amneal Pharmaceuticals (AMRX) raise or lower guidance?

When did Amneal Pharmaceuticals (AMRX) last issue guidance?

People Also Watch

Amneal Pharmaceuticals Guidance History

FAQ

What is the most recent guidance for Amneal Pharmaceuticals (AMRX)?

What EPS range did Amneal Pharmaceuticals (AMRX) guide for?

What revenue range did Amneal Pharmaceuticals (AMRX) guide for?

Did Amneal Pharmaceuticals (AMRX) raise or lower guidance?

When did Amneal Pharmaceuticals (AMRX) last issue guidance?

People Also Watch